
Announcement:
End of employment CEO Bilthoven Biologicals
The Serum Institute of India Pvt., Ltd., the Supervisory Board and CEO of Bilthoven Biologicals B.V. have agreed that the CEO steps down as Managing Director on March 31st, 2023.
Jan-Eric Zandbergen has been CEO of Bilthoven Biologicals B.V. since 2017. During these years de production volume increased tremendously and the number of employees grew from 180 to 500.
The tasks of the CEO are temporarily taken over by Jef de Clercq. We would like to thank Jan-Eric for his unbridled efforts for Bilthoven Biologicals B.V.
About BBio
Bilthoven Biologicals B.V, owned by the Serum Institute of India Pvt., Ltd., since 2012, is a vaccine manufacturing company located in Bilthoven, on the Utrechts Science Park Bilthoven. The company mainly produces polio vaccines. In addition, it is the exclusive supplier of BCG for the follow-up treatment of bladder cancer.
Share |
|